Shanghai, China

Nian Gong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pegbio Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nian Gong. Retrieved from https://idiyas.com/inventor/nian-gong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nian Gong: Innovator in Diabetes Treatment

Introduction

Nian Gong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of diabetes treatment through his innovative research and development.

Latest Patents

Nian Gong holds a patent for an Exendin variant and its conjugate. This invention provides a novel Exendin variant and the Exendin variant conjugate conjugating polymer. The pharmaceutical composition comprising these elements is designed for treating diseases such as reducing blood glucose and treating diabetes, particularly Type II diabetes. Additionally, the invention offers the use of the Exendin conjugate for lowering body weight.

Career Highlights

Nian Gong is associated with Pegbio Co., Ltd., where he continues to advance his research in the pharmaceutical field. His work has garnered attention for its potential impact on diabetes management.

Collaborations

Some of his notable coworkers include Michael Min Xu and Yinghui Zhang, who contribute to the innovative environment at Pegbio Co., Ltd.

Conclusion

Nian Gong's contributions to diabetes treatment through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work continues to pave the way for advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…